FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

J J P Kastelein

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
R P Surendran; M E Visser; J Wang; J C Defesche; S Heemelaar; R A Hegele; M Hosseini; C T Johansen; J J P Kastelein; J A Kuivenhoven; J Peter; Miklós Péterfy; E S G Stroes; G M Dallinga-Thie
Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia.
Liam R Brunham; Bruce Carleton; C Carter; G Kees Hovingh; J W Jukema; J J P Kastelein; Peter J Lansberg; Fudan Miao; Colin J D Ross; A F Stalenhoef; Henk Visscher; L Zhang; Michael R Hayden
Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin.
R Huijgen; Barbara A Hutten; M Denoun; Sigrid W Fouchier; G Lambert; Maud N Vissers; J J P Kastelein
Plasma levels of PCSK9 and phenotypic variability in familial hypercholesterolemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of J J P Kastelein (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: R P Surendran; M E Visser; J Wang; J C Defesche; S Heemelaar; R A Hegele; M Hosseini; C T Johansen; J J P Kastelein; J A Kuivenhoven; J Peter; Miklós Péterfy; E S G Stroes; G M Dallinga-Thie
Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia.
Journal of internal medicine 2012;272(2):185-96.
2012: Liam R Brunham; Bruce Carleton; C Carter; G Kees Hovingh; J W Jukema; J J P Kastelein; Peter J Lansberg; Fudan Miao; Colin J D Ross; A F Stalenhoef; Henk Visscher; L Zhang; Michael R Hayden
Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin.
The pharmacogenomics journal 2012;12(3):233-7.
2012: R Huijgen; Barbara A Hutten; M Denoun; Sigrid W Fouchier; G Lambert; Maud N Vissers; J J P Kastelein
Plasma levels of PCSK9 and phenotypic variability in familial hypercholesterolemia.
Journal of lipid research 2012;53(5):979-83.
2011: B Sjouke; J J P Kastelein; D M Kusters; G Kees Hovingh
Familial hypercholesterolemia: present and future management.
Current cardiology reports 2011;13(6):527-36.
2011: K L Rensing; A Q Reuwer; Benoit J Arsenault; J B L Hoekstra; J J P Kastelein; Jan H von der Thüsen; Th B Twickler
Reducing cardiovascular disease risk in patients with type 2 diabetes and concomitant macrovascular disease: can insulin be too much of a good thing?
Diabetes, obesity & metabolism 2011;13(12):1073-87.
2011: S Sivapalaratnam; Mohammad Mahdi Motazacker; S Maiwald; G Kees Hovingh; J J P Kastelein; M Levi; Mieke D Trip; Geesje M Dallinga-Thie
Genome-wide association studies in atherosclerosis.
Current atherosclerosis reports 2011;13(3):225-32.
2011: A G Holleboom; Jan Albert Kuivenhoven; C C van Olden; J Peter; A W Schimmel; Johannes Levels; Robert M Valentijn; P Vos; Joep C Defesche; J J P Kastelein; G Kees Hovingh; E S G Stroes; C E M Hollak
Proteinuria in early childhood due to familial LCAT deficiency caused by loss of a disulfide bond in lecithin:cholesterol acyl transferase.
Atherosclerosis 2011;216(1):161-5.
2010: S Sivapalaratnam; L L van Loendersloot; Barbara A Hutten; J J P Kastelein; Mieke D Trip; Eric de Groot
Long-term LDL-c lowering in heterozygous familial hypercholesterolemia normalizes carotid intima-media thickness.
Atherosclerosis 2010;212(2):571-4.
2010: Maud M Geenen; P J M Bakker; leontien c kremer; J J P Kastelein; F E van Leeuwen
Increased prevalence of risk factors for cardiovascular disease in long-term survivors of acute lymphoblastic leukemia and Wilms tumor treated with radiotherapy.
Pediatric blood & cancer 2010;55(4):690-7.
2010: Ingar Holme; R Fayyad; Ole Faergeman; J J P Kastelein; Anders G Olsson; Matti J Tikkanen; Mogens Lytken Larsen; C Lindahl; Hallvard Holdaas; T R Pedersen
Cardiovascular outcomes and their relationships to lipoprotein components in patients with and without chronic kidney disease: results from the IDEAL trial.
Journal of internal medicine 2010;267(6):567-75.
2010: H J Avis; H J Scheffer; J J P Kastelein; G M Dallinga-Thie; F A Wijburg
Pink-creamy whole blood in a 3-month-old infant with a homozygous deletion in the lipoprotein lipase gene.
Clinical genetics 2010;77(5):430-3.
2010: L Jakulj; Maud N Vissers; Albert K Groen; Barbara A Hutten; D Lutjohann; E P Veltri; J J P Kastelein
Baseline cholesterol absorption and the response to ezetimibe/simvastatin therapy: a post-hoc analysis of the ENHANCE trial.
Journal of lipid research 2010;51(4):755-62.
2010: A H Pijlman; R Huijgen; S N Verhagen; B P M Imholz; A H Liem; J J P Kastelein; E J Abbink; A F H Stalenhoef; Frank L J Visseren
Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large cross-sectional study in The Netherlands.
Atherosclerosis 2010;209(1):189-94.
2010: B J Arsenault; J S Rana; I Lemieux; Jean-Pierre Després; J J P Kastelein; S M Boekholdt; N J Wareham; K-T Khaw
Physical inactivity, abdominal obesity and risk of coronary heart disease in apparently healthy men and women.
International journal of obesity (2005) 2010;34(2):340-7.
2010: A G Holleboom; Jan Albert Kuivenhoven; M Vergeer; G Kees Hovingh; Joram N I van Miert; Nicholas J Wareham; J J P Kastelein; Kay-Tee Khaw; S Matthijs Boekholdt
Plasma levels of lecithin:cholesterol acyltransferase and risk of future coronary artery disease in apparently healthy men and women: a prospective case-control analysis nested in the EPIC-Norfolk population study.
Journal of lipid research 2010;51(2):416-21.
2009: E S G Stroes; J J P Kastelein; A Bénardeau; O Kuhlmann; D Blum; L A Campos; R G Clerc; E J Niesor
Dalcetrapib: no off-target toxicity on blood pressure or on genes related to the renin-angiotensin-aldosterone system in rats.
British journal of pharmacology 2009;158(7):1763-70.
2009: Anouk van der Graaf; J J P Kastelein; Albert Wiegman
Heterozygous familial hypercholesterolaemia in childhood: cardiovascular risk prevention.
Journal of inherited metabolic disease 2009;32(6):699-705.
2009: J S Rana; M Cote; J-P Després; M S Sandhu; P J Talmud; E Ninio; N J Wareham; J J P Kastelein; A H Zwinderman; K-T Khaw; S M Boekholdt
Inflammatory biomarkers and the prediction of coronary events among people at intermediate risk: the EPIC-Norfolk prospective population study.
Heart (British Cardiac Society) 2009;95(20):1682-7.
2009: K E L Harchaoui; M E Visser; J J P Kastelein; Erik S G Stroes; G M Dallinga-Thie
Triglycerides and cardiovascular risk.
Current cardiology reviews 2009;5(3):216-22.
2009: C A Wijbrandts; S I van Leuven; H D Boom; D M Gerlag; E G S Stroes; J J P Kastelein; P P Tak
Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritis.
Annals of the rheumatic diseases 2009;68(8):1316-21.
2009: R Duivenvoorden; Eric de Groot; B M Elsen; Johan S Laméris; R J van der Geest; Erik S G Stroes; J J P Kastelein; Aart J Nederveen
In vivo quantification of carotid artery wall dimensions: 3.0-Tesla MRI versus B-mode ultrasound imaging.
Circulation. Cardiovascular imaging 2009;2(3):235-42.
2009: M de Fost; M Langeveld; R Franssen; B A Hutten; J E M Groener; E de Groot; M M Mannens; H Bikker; J M F G Aerts; J J P Kastelein; C E M Hollak
Low HDL cholesterol levels in type I Gaucher disease do not lead to an increased risk of cardiovascular disease.
Atherosclerosis 2009;204(1):267-72.
2009: H C Hassing; Th B Twickler; J J P Kastelein; M J M Cramer; F R Cassee
Air pollution as noxious environmental factor in the development of cardiovascular disease.
The Netherlands journal of medicine 2009;67(4):116-21.
2009: R Franssen; M Vergeer; Erik S G Stroes; J J P Kastelein
Combination statin-fibrate therapy: safety aspects.
Diabetes, obesity & metabolism 2009;11(2):89-94.
2009: M van Hoek; Arie Van Tol; L C van Vark-van der Zee; Hans Jansen; J J P Kastelein; Eric J G Sijbrands; Geesje M Dallinga-Thie
Role of plasma adiponectin on the HDL-cholesterol raising effect of atorvastatin in patients with type 2 diabetes.
Current medical research and opinion 2009;25(1):93-101.
2008: B Dorfmeister; W W Zeng; A Dichlberger; S K Nilsson; F G Schaap; J A Hubacek; Martin Merkel; Jackie A Cooper; A Lookene; Wendy Putt; R Whittall; P J Lee; laurence lins; N Delsaux; M Nierman; J A Kuivenhoven; J J P Kastelein; M Vrablik; Gunilla Olivecrona; W J Schneider; J Heeren; Steve E Humphries; Philippa J Talmud
Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(10):1866-71.
2008: CI Wright; H J Scholten; J C M Schilder; B M Elsen; W Hanselaar; CI Kroner; R Draijer; J J P Kastelein; W Stok; J Karemaker; E de Groot
Arterial stiffness, endothelial function and microcirculatory reactivity in healthy young males.
Clinical physiology and functional imaging 2008;28(5):299-306.
2008: Max Nieuwdorp; M Vergeer; Radjesh J Bisoendial; J op 't Roodt; Johannes Levels; Rakesh S Birjmohun; J A Kuivenhoven; R Basser; ton rabelink; J J P Kastelein; Erik S G Stroes
Reconstituted HDL infusion restores endothelial function in patients with type 2 diabetes mellitus.
Diabetologia 2008;51(6):1081-4.
2007: Jamal S Rana; S Matthijs Boekholdt; P M Ridker; J Wouter Jukema; R Luben; S A Bingham; Nicholas E Day; Nicholas J Wareham; J J P Kastelein; Kay-Tee Khaw
Differential leucocyte count and the risk of future coronary artery disease in healthy men and women: the EPIC-Norfolk Prospective Population Study.
Journal of internal medicine 2007;262(6):678-89.
2007: Max Nieuwdorp; Erik S G Stroes; J J P Kastelein
Normalization of metabolic syndrome using fenofibrate, metformin or their combination.
Diabetes, obesity & metabolism 2007;9(6):869-78.
2007: H J Avis; Maud N Vissers; E A Stein; Frits A Wijburg; Mieke D Trip; J J P Kastelein; Barbara A Hutten
A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(8):1803-10.
2007: Rakesh S Birjmohun; J J P Kastelein; D Poldermans; Erik S G Stroes; U Hostalek; G Assmann
Safety and tolerability of prolonged-release nicotinic acid in statin-treated patients.
Current medical research and opinion 2007;23(7):1707-13.
2007: Max Nieuwdorp; Frits Holleman; Eric de Groot; Hans Vink; J Gort; Anatol Kontush; M John Chapman; Barbara A Hutten; C B Brouwer; J B L Hoekstra; J J P Kastelein; Erik S G Stroes
Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosis.
Diabetologia 2007;50(6):1288-93.
2007: Jamal S Rana; Max Nieuwdorp; J Wouter Jukema; J J P Kastelein
Cardiovascular metabolic syndrome - an interplay of, obesity, inflammation, diabetes and coronary heart disease.
Diabetes, obesity & metabolism 2007;9(3):218-32.
2006: Rakesh S Birjmohun; Wim A van der Steeg; Erik S G Stroes; J J P Kastelein
[The role of the high-density lipoprotein (HDL) particle in atherogenesis and potential methods to increase HDL concentrations].
Nederlands tijdschrift voor geneeskunde 2006;150(41):2245-50.
2006: Jamal S Rana; Angelique C M Jansen; Aeilko H Zwinderman; Emily S van Aalst-Cohen; J Wouter Jukema; Mieke D Trip; J J P Kastelein
Lipoprotein (a) and risk of cardiovascular disease in patients with metabolic syndrome in a population of familial hypercholesterolaemia.
Journal of internal medicine 2006;260(2):183-5.
2006: Wim G Goettsch; E M Heintjes; J J P Kastelein; ton rabelink; Saga Johansson; Ron Herings
Results from a rosuvastatin historical cohort study in more than 45,000 Dutch statin users, a PHARMO study.
Pharmacoepidemiology and drug safety 2006;15(7):435-43.
2006: S Matthijs Boekholdt; Olga Souverein; Michael W T Tanck; G Kees Hovingh; Jan Albert Kuivenhoven; R I G Peters; H Jansen; Paul M H Schiffers; Ernst E van der Wall; Pieter A Doevendans; P H Reitsma; Aeilko H Zwinderman; J J P Kastelein; J Wouter Jukema
Common variants of multiple genes that control reverse cholesterol transport together explain only a minor part of the variation of HDL cholesterol levels.
Clinical genetics 2006;69(3):263-70.
2006: Thor Ueland; Maud N Vissers; Albert Wiegman; Jessica Rodenburg; Barbara A Hutten; Lars Gullestad; Leiv Ose; N Rifai; P M Ridker; J J P Kastelein; Pål Aukrust; Anne G Semb
Increased inflammatory markers in children with familial hypercholesterolaemia.
European journal of clinical investigation 2006;36(3):147-52.
2006: E P Walma; Frank L J Visseren; J Wouter Jukema; J J P Kastelein; Arno Hoes; Anton F H Stalenhoef
[The practice guideline 'Diagnosis and treatment of familial hypercholesterolaemia' of the Dutch Health Care Insurance Board].
Nederlands tijdschrift voor geneeskunde 2006;150(1):18-23.
2006: Sander I van Leuven; J J P Kastelein; D P D'Cruz; G R Hughes; Erik S G Stroes
Atherogenesis in rheumatology.
Lupus 2006;15(3):117-21.
2005: Wim A van der Steeg; Karim El Harchaoui; Jan Albert Kuivenhoven; J J P Kastelein
Increasing high-density lipoprotein cholesterol through cholesteryl Ester transfer protein inhibition: a next step in the fight against cardiovascular disease?
Current drug targets. Cardiovascular & haematological disorders 2005;5(6):481-8.
2005: Eric de Groot; G Kees Hovingh; Aeilko H Zwinderman; Albert Wiegman; Andries J Smit; J J P Kastelein
Data density curves of B-mode ultrasound arterial wall thickness measurements in unaffected control and at-risk populations.
International angiology : a journal of the International Union of Angiology 2005;24(4):359-65.
2005: J J P Kastelein; Raaj R Sankatsing
Ezetimibe/simvastatin (INEGY) in the treatment of hyperlipidaemia.
International journal of clinical practice 2005;59(12):1464-71.
2005: A F E Bots; J J P Kastelein
Achieving lipid goals in real life: the Dutch DISCOVERY study.
International journal of clinical practice 2005;59(12):1387-94.
2005: Pim van der Harst; J J P Kastelein; W H van Gilst
[Statins: for the time being, do not as a rule prescribe the maximum dose].
Nederlands tijdschrift voor geneeskunde 2005;149(46):2589; author reply 2589-90.
2005: Joris W J Vriend; Eric de Groot; Berto J Bouma; Jana Hrudova; J J P Kastelein; Jan G P Tijssen; Barbara J M Mulder
Carotid intima-media thickness in post-coarctectomy patients with exercise induced hypertension.
Heart (British Cardiac Society) 2005;91(7):962-3.
2005: Riza C Ozsoy; Marion G Koopman; J J P Kastelein; Lambertus Arisz
The acute effect of atorvastatin on proteinuria in patients with chronic glomerulonephritis.
Clinical nephrology 2005;63(4):245-9.
2005: Sigrid W Fouchier; Raaj R Sankatsing; J Peter; Sergio Castillo; Miguel Pocovi; R Alonso; J J P Kastelein; Joep C Defesche
High frequency of APOB gene mutations causing familial hypobetalipoproteinaemia in patients of Dutch and Spanish descent.
Journal of medical genetics 2005;42(4):e23.
2005: S Matthijs Boekholdt; Frank M Sacks; J Wouter Jukema; James Shepherd; Dilys J Freeman; Alex D McMahon; F Cambien; V Nicaud; Greetje J de Grooth; P J Talmud; S E Humphries; George J Miller; Gudny Eiriksdottir; Vilmundur Gudnason; Heikki Kauma; Sakari Kakko; Markku Savolainen; Marcello Arca; Anna Montali; S Liu; H J Lanz; Aeilko H Zwinderman; Jan Albert Kuivenhoven; J J P Kastelein
Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects.
Circulation 2005;111(3):278-87.
2005: Melchior C Nierman; Jaap Rip; Jaap Twisk; J J M Meulenberg; J J P Kastelein; Erik S G Stroes; Jan Albert Kuivenhoven
Gene therapy for genetic lipoprotein lipase deficiency: from promise to practice.
The Netherlands journal of medicine 2005;63(1):14-9.
2004: Angelique C M Jansen; Emily S van Aalst-Cohen; Michael W T Tanck; Mieke D Trip; Peter J Lansberg; A H Liem; H W O Roeters van Lennep; Eric J G Sijbrands; J J P Kastelein
The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients.
Journal of internal medicine 2004;256(6):482-90.
2004: Wim A van der Steeg; Jan Albert Kuivenhoven; Anke H E M Klerkx; S Matthijs Boekholdt; G Kees Hovingh; J J P Kastelein
Role of CETP inhibitors in the treatment of dyslipidemia.
Current opinion in lipidology 2004;15(6):631-6.
2004: Jessica Rodenburg; Maud N Vissers; Mieke D Trip; Albert Wiegman; Henk D Bakker; J J P Kastelein
The spectrum of statin therapy in hyperlipidemic children.
Seminars in vascular medicine 2004;4(4):313-20.
2004: Rakesh S Birjmohun; Barbara A Hutten; J J P Kastelein; Erik S G Stroes
Increasing HDL cholesterol with extended-release nicotinic acid: from promise to practice.
The Netherlands journal of medicine 2004;62(7):229-34.
2004: Jessica Rodenburg; Albert Wiegman; Maud N Vissers; J J P Kastelein; Anton F H Stalenhoef
A boy with autosomal recessive hypercholesterolaemia.
The Netherlands journal of medicine 2004;62(3):89-93.
2004: J J W Vriend; Eric de Groot; J J P Kastelein; Barbara J M Mulder
Carotid and femoral B-mode ultrasound intima-media thickness measurements in adult post-coarctectomy patients.
International angiology : a journal of the International Union of Angiology 2004;23(1):41-6.
2004: Mihai G Netea; Anneke Hijmans; Sanne van Wissen; Tineke J Smilde; Mieke D Trip; Bart Jan Kullberg; Theo M de Boo; J W M Van Der Meer; J J P Kastelein; Anton F H Stalenhoef; A F H Stalenhorf
Toll-like receptor-4 Asp299Gly polymorphism does not influence progression of atherosclerosis in patients with familial hypercholesterolaemia.
European journal of clinical investigation 2004;34(2):94-9.
2004: G Kees Hovingh; Jan Albert Kuivenhoven; Radjesh J Bisoendial; Albert K Groen; Marjel J van Dam; Arie Van Tol; Cheryl L Wellington; Michael R Hayden; August Smelt; J J P Kastelein
HDL deficiency and atherosclerosis: lessons from Tangier disease.
Journal of internal medicine 2004;255(2):299-301.
2004: Anke H E M Klerkx; Greetje J de Grooth; Aeilko H Zwinderman; J Wouter Jukema; Jan Albert Kuivenhoven; J J P Kastelein
Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS).
European journal of clinical investigation 2004;34(1):21-8.
2003: Jan Albert Kuivenhoven; G Kees Hovingh; Arie Van Tol; M Jauhiainen; C Ehnholm; Jean-Charles Fruchart; E A Brinton; J D Otvos; August Smelt; A Brownlee; Aeilko H Zwinderman; Michael R Hayden; J J P Kastelein
Heterozygosity for ABCA1 gene mutations: effects on enzymes, apolipoproteins and lipoprotein particle size.
Atherosclerosis 2003;171(2):311-9.
2003: CF Hoogendijk; Charlotte L Scholtz; S M Pimstone; E Ehrenborg; J J P Kastelein; JC Defesche; Rochelle Thiart; Lana du Plessis; Nico de Villiers; Monique G Zaahl; Rhena Delport; David C Rubinsztein; L J Raffel; Clarence Grim; S Mediene-Benchekor; P Amouyel; T Brousseau; Krisela Steyn; Carl Lombard; Michael R Hayden; Maritha J Kotze
Allelic variation in the promoter region of the LDL receptor gene: analysis of an African-specific variant in the FP2 cis-acting regulatory element.
Molecular and cellular probes 2003;17(4):175-81.
2003: Sanne van Wissen; Tineke J Smilde; Mieke D Trip; Theo M de Boo; J J P Kastelein; Anton F H Stalenhoef
Long term statin treatment reduces lipoprotein(a) concentrations in heterozygous familial hypercholesterolaemia.
Heart (British Cardiac Society) 2003;89(8):893-6.
2003: Joris Rotmans; Evelyn Velema; Hence J M Verhagen; Jan D Blankensteijn; J J P Kastelein; Dominique P V de Kleijn; M Yo; Gerard Pasterkamp; Erik S G Stroes
Rapid, arteriovenous graft failure due to intimal hyperplasia: a porcine, bilateral, carotid arteriovenous graft model.
The Journal of surgical research 2003;113(1):161-71.
2003: J J P Kastelein
The future of lipid-lowering therapy: the big picture.
The Netherlands journal of medicine 2003;61(5 Suppl):35-9.
2003: Michael W T Tanck; Anke H E M Klerkx; J Wouter Jukema; P De Knijff; J J P Kastelein; Aeilko H Zwinderman
Estimation of multilocus haplotype effects using weighted penalised log-likelihood: analysis of five sequence variations at the cholesteryl ester transfer protein gene locus.
Annals of human genetics 2003;67(Pt 2):175-84.
2003: Pernette R W de Sauvage Nolting; Joep C Defesche; Rudolf J A Buirma; Barbara A Hutten; Peter J Lansberg; J J P Kastelein
Prevalence and significance of cardiovascular risk factors in a large cohort of patients with familial hypercholesterolaemia.
Journal of internal medicine 2003;253(2):161-8.
2003: Saskia de Jongh; Maud N Vissers; P Rol; Henk D Bakker; J J P Kastelein; Erik S G Stroes
Plant sterols lower LDL cholesterol without improving endothelial function in prepubertal children with familial hypercholesterolaemia.
Journal of inherited metabolic disease 2003;26(4):343-51.
2003: Riza C Ozsoy; J J P Kastelein; Lambertus Arisz; Marion G Koopman
Atorvastatin and the dyslipidemia of early renal failure.
Atherosclerosis 2003;166(1):187-94.
2002: Marina Umans-Eckenhausen; Frans J Oort; K C M P Ferenschild; Joep C Defesche; J J P Kastelein; J C J M de Haes
Parental attitude towards genetic testing for familial hypercholesterolaemia in children.
Journal of medical genetics 2002;39(9):e49.
2002: Marjel J van Dam; M Zwart; Femke de Beer; August Smelt; Martin H Prins; Mieke D Trip; Louis M Havekes; Peter J Lansberg; J J P Kastelein
Long term efficacy and safety of atorvastatin in the treatment of severe type III and combined dyslipidaemia.
Heart (British Cardiac Society) 2002;88(3):234-8.
2002: Karin Zwarts; Susanne M Clee; Aeilko H Zwinderman; J C Engert; Roshni R Singaraja; Odell Loubser; Erick James; Kirsten Roomp; T J Hudson; J Wouter Jukema; J J P Kastelein; Michael R Hayden
ABCA1 regulatory variants influence coronary artery disease independent of effects on plasma lipid levels.
Clinical genetics 2002;61(2):115-25.